
The results of our phase I glioblastoma clinical trial have been published, and we’re excited to share them with the world.
The findings of our phase I glioblastoma clinical trial have been published in the international Journal of Clinical Neuroscience. The results of the trial show that the treatment is safe, well-tolerated and may improve the life expectancy of patients with glioblastoma.